Seroprevalence of viral hepatitis B, C and E in TB patients from the Republic of Moldova
pdf

Keywords

seroprevalence
laboratory investigations
viral hepatitis B, C and E
TB patients

How to Cite

SAJIN, O., SPINU, C., ISAC, M., IZIUMOV, N., CHERNIAVSKA, A., BUGA, A. and CIOBANU, I. (2023) “Seroprevalence of viral hepatitis B, C and E in TB patients from the Republic of Moldova”, One Health & Risk Management , 4(1), pp. 59-64. doi: 10.38045/ohrm.2023.1.07.

Abstract

Introduction. For the first time, in the Republic of Moldova, there was established the seroprevalence of viral hepatitis B, C and E markers in patients with tuberculosis depending on gender, age and geographical areas.

Material and methods. 200 blood samples were collected from patients with tuberculosis and tested by the immuno-fermentative method for presence of viral hepatitis B, C and E markers.

Results. Following the investigations, it was established that the seroprevalence of the anti-HEV Ig marker in patients with tuberculosis is 12.0±2.3%. The seroprevalence of viral hepatitis B marker HBsAg in patients with tuberculosis was 13.5±2.4%, and that of viral hepatitis C anti-HCV – 9.0±2.0%. The study of investigations results for the presence of nominated markers depending on the geographical areas showed a significant statistically difference in the seroprevalence of the anti-HEV IgG marker in TB patients in the Central area of the country compared to the Southern area(p<0.05).

Conclusions. Patients with tuberculosis have a higher risk of developing viral hepatitis B, C and E, mainly affecting people aged 40-49 and > 60 years, including males.

https://doi.org/10.38045/ohrm.2023.1.07
pdf

|Views: 24| |pdf Downloads: 1|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Octavian Sajin

Downloads

Download data is not yet available.